Sex-specific Heart Failure Burden Across the United States: Global Burden of Disease 1990-2019.

Epidemiology Global Burden of Disease Heart failure

Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
16 Dec 2023
Historique:
received: 23 08 2023
revised: 30 11 2023
accepted: 10 12 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 18 12 2023
Statut: aheadofprint

Résumé

Heart failure (HF) has unique aspects that vary by biological sex. Thus, understanding sex-specific trends of HF in the US population is crucial to develop targeted interventions. We aimed to analyze the burden of HF in female and male patients across the US, from 1990 to 2019. Using the Global Burden of Disease (GBD) study data from 2019, we performed an analysis of the burden of HF from 1990-2019, across US states and regions. The GBD defined HF through studies that used symptom-based criteria and expressed the burden of HF as the age-adjusted prevalence and Years Lived with Disability (YLDs) rates per 100,000 individuals. The age-adjusted prevalence of HF for the US in 2019 was 926.2 (95% UI, [799.6, 1079.0]) for females and 1291.2 (95% UI, [1104.1, 1496.8]) for males. Notably, our findings also highlight cyclic fluctuations in HF prevalence over time, with peaks occurring in the mid-1990s and around 2010, while reaching its lowest points in around 2000 and 2018. Among individuals >70 years of age, the absolute number of individuals with HF was higher in females, and this age group doubled the absolute count between 1990 and 2019. Comparing 1990-1994 to 2015-2019, 10 states had increased female HF prevalence, while only 4 states increased male prevalence. Overall, Western states had the greatest relative decline in HF burden, in both sexes. The burden of HF in the US is high, although the magnitude of this burden varies according to age, sex, state, and region. There is a significant increase in the absolute number of individuals with HF, especially among women >70 years, expected to continue due to the aging population.

Sections du résumé

BACKGROUND BACKGROUND
Heart failure (HF) has unique aspects that vary by biological sex. Thus, understanding sex-specific trends of HF in the US population is crucial to develop targeted interventions. We aimed to analyze the burden of HF in female and male patients across the US, from 1990 to 2019.
METHODS METHODS
Using the Global Burden of Disease (GBD) study data from 2019, we performed an analysis of the burden of HF from 1990-2019, across US states and regions. The GBD defined HF through studies that used symptom-based criteria and expressed the burden of HF as the age-adjusted prevalence and Years Lived with Disability (YLDs) rates per 100,000 individuals.
RESULTS RESULTS
The age-adjusted prevalence of HF for the US in 2019 was 926.2 (95% UI, [799.6, 1079.0]) for females and 1291.2 (95% UI, [1104.1, 1496.8]) for males. Notably, our findings also highlight cyclic fluctuations in HF prevalence over time, with peaks occurring in the mid-1990s and around 2010, while reaching its lowest points in around 2000 and 2018. Among individuals >70 years of age, the absolute number of individuals with HF was higher in females, and this age group doubled the absolute count between 1990 and 2019. Comparing 1990-1994 to 2015-2019, 10 states had increased female HF prevalence, while only 4 states increased male prevalence. Overall, Western states had the greatest relative decline in HF burden, in both sexes.
CONCLUSION CONCLUSIONS
The burden of HF in the US is high, although the magnitude of this burden varies according to age, sex, state, and region. There is a significant increase in the absolute number of individuals with HF, especially among women >70 years, expected to continue due to the aging population.

Identifiants

pubmed: 38109986
pii: S0002-8703(23)00348-4
doi: 10.1016/j.ahj.2023.12.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Pedro Rvo Salerno (PR)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.

Zhuo Chen (Z)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.

Sojin Wass (S)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.

Issam Motairek (I)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.

Chantal Elamm (C)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH; Section of Advanced Heart Failure and Transplantation, University Hospitals, Cleveland, OH.

Lúcia Mvo Salerno (LM)

Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil.

Neda Shafiabadi Hassani (NS)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.

Salil V Deo (SV)

Surgical Services, Louis Stokes VA Hospital, Cleveland, OH.

Sadeer G Al-Kindi (SG)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH; Section of Advanced Heart Failure and Transplantation, University Hospitals, Cleveland, OH. Electronic address: Sadeer.Al-Kindi@uhhospitals.org.

Classifications MeSH